Personalized Medicine for Neuroblastoma: Moving from Static Genotypes to Dynamic Simulations of Drug Response.

J Pers Med · 2021 · PMC8151552 · PMID 34064704

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Importantly, this study demonstrated that impaired JNK activation in silico was a highly significant and independent indicator of poor overall survival for neuroblastoma patients.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.